Wednesday, May 27, 2015

Decisions in the cases of Kateryna Kozlova and Hamad Abbas Janahi

PRESS RELEASE
27 May 2015

Decision in the case of Kateryna Kozlova

The International Tennis Federation announced today that Kateryna Kozlova has been found to have committed an Anti-Doping Rule Violation under Article 2.1 of the Tennis Anti-Doping Programme (presence of a Prohibited Substance in a Player’s Sample).

Ms Kozlova, a 21 year-old player from Ukraine, provided a urine sample on 16 February 2015 in association with her participation in the 2015 Dubai Duty Free Tennis Championships event (the “Dubai event”) held in Dubai, UAE. That sample was sent to the WADA-accredited laboratory in Montreal, Canada for analysis, and was found to contain 1,3 dimethylbutylamine, which is a Prohibited Substance under section S6(b) (Stimulants) of the 2015 WADA List of Prohibited Substances and Prohibited Methods, and is therefore also prohibited under the Tennis Anti-Doping Programme (the “Programme”). Ms Kozlova was therefore charged with an Anti-Doping Rule Violation under Article 2.1 of the Programme.

Ms Kozlova asserted that the 1,3 dimethylbutylamine, for which she did not hold a valid TUE, had entered her system through her ingestion of a supplement provided to her by a doctor. The ITF accepted that Ms Kozlova had therefore established the means by which the 1,3 dimethylbutylamine entered her system, and that she met the preconditions of Article 10.5 of the 2015 Programme (reduction of the period of ineligibility based on no significant fault or negligence).

Ms Kozlova’s commission of an Anti-Doping Rule Violation under Article 2.1 of the Programme was confirmed, and it was determined that she is suspended from participation for a period of six months, back-dated to commence from 16 February 2015, and so ending at midnight on 15 August 2015. It was also determined that her results at the Dubai event – and all subsequent events in which she competed prior to the date of this decision – should be disqualified, with resulting forfeiture of the ranking points and prize money that she won at those events.


The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.

 


PRESS RELEASE
27 May 2015

Decision in the case of Hamad Abbas Janahi

The International Tennis Federation announced today that Hamad Abbas Janahi has been found to have committed an Anti-Doping Rule Violation under Article 2.1 of the Tennis Anti-Doping Programme (presence of a Prohibited Substance in a Player’s Sample).

Mr Janahi, a 24 year-old player from UAE, provided a urine sample on 21 February 2015 in association with his participation in the 2015 Dubai Duty Free Tennis Championships event (the “Dubai event”) held in Dubai, UAE. That sample was sent to the WADA-accredited laboratory in Montreal, Canada for analysis, and was found to contain a metabolite of methylphenidate and 1,3-dimethylbutylamine, which are Prohibited Substances under section S6(b) (Stimulants) of the 2015 WADA List of Prohibited Substances and Prohibited Methods, and are therefore also prohibited under the Tennis Anti-Doping Programme (the “Programme”). Mr Janahi was therefore charged with an Anti-Doping Rule Violation under Article 2.1 of the Programme.

Mr Janahi’s commission of an Anti-Doping Rule Violation under Article 2.1 of the Programme was confirmed, and it was determined that he is suspended from participation for a period of two years, commencing on 27 May 2015, and so ending at midnight on 26 May 2017. It was also determined that his results at the Dubai event should be disqualified, with resulting forfeiture of the ranking points and prize money that he won at those events.


The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.

5 comments:

  1. Two more superstars brought down by the effective testing!

    ReplyDelete
    Replies
    1. you made me laugh!!

      very good ironic gag!!

      Ciao!

      Fabrice

      Delete
  2. "The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme"

    Christ they really can just write what they want in these press releases can't they?

    ReplyDelete
  3. Interesting that months go by without any positive tests, then suddenly two players are busted from a single event with samples tested by a specific lab. Makes me wonder whether someone threatened to leak the positive tests if the players weren't properly sanctioned.

    ReplyDelete
  4. I might be wrong, but it seems to me that these announcements tend to come during larger events... Is this a PR strategy to tel the world, when it's paying attention, that tennis tests and catches?

    Regardless, 2 more minnows tagged for stimulants. Not relevant in the bigger picture, IMO

    ReplyDelete